ScholarIQanswers from OpenAlex
Yokohama City University Medical Center
InstitutionResearch output, impact & collaborations
Yokohama City University Medical Center is a institution indexed in ScholarIQ from OpenAlex.
What is known about Yokohama City University Medical Center?
ScholarIQrecord summary
Yokohama City University Medical Center is a research organisation in Yokohama, JP. OpenAlex records 7,349 works and 359,479 citations for it. 1,548 researchers list it as their most recent affiliation.
How many works does Yokohama City University Medical Center have?
ScholarIQindexed works
Yokohama City University Medical Center has 7,349 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Yokohama City University Medical Center have?
ScholarIQcitation count
Yokohama City University Medical Center has 359,479 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Yokohama City University Medical Center?
ScholarIQresearcher count
Yokohama City University Medical Center has 1,548 researchers in the ScholarIQ index.
What is the average h-index at Yokohama City University Medical Center?
ScholarIQavg h-index
Yokohama City University Medical Center has an average h-index of 40.8 in OpenAlex.
What is the ROR of Yokohama City University Medical Center?
ScholarIQror
The ROR for Yokohama City University Medical Center is on the source record.
What is the OpenAlex record for Yokohama City University Medical Center?
ScholarIQopenalex
The OpenAlex for Yokohama City University Medical Center is on the source record.
What is the Wikidata of Yokohama City University Medical Center?
ScholarIQwikidata
The Wikidata for Yokohama City University Medical Center is on the source record.
Who are the most-cited researchers behind Yokohama City University Medical Center?
ScholarIQtop researchers by citations
What are the most-cited papers on Yokohama City University Medical Center?
ScholarIQmost cited works
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen, Richard S. Finn, Peter R. Galle, Josep M. Llovet, Eric Assénat, Giovanni Brandi, Marc Pracht, Ho Yeong Lim, Kun‐Ming Rau, Kenta Motomura, Izumi Ohno, Philippe Merle, Bruno Daniele, Dong Bok Shin, Guido Gerken, Christophe Borg, Jean‐Baptiste Hiriart, Takuji Okusaka, Manabu Morimoto, Yanzhi Hsu, Paolo Abada, Masatoshi Kudo
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Patrício Godoy, Nicola J. Hewitt, Ute Albrecht, Melvin E. Andersen, Nariman Ansari, Sudin Bhattacharya, Johannes G. Bode, Jennifer Bolleyn, Christoph Borner, J Böttger, Albert Braeuning, Robert A. Budinsky, Britta Burkhardt, Neil R. Cameron, Giovanni Camussi, Chong-Su Cho, Yun-Jaie Choi, J. Craig Rowlands, Uta Dahmen, Georg Damm, Olaf Dirsch, M. Teresa Donato, Jian Dong, Steven Dooley, Dirk Drasdo, Rowena Eakins, Karine Sá Ferreira, Valentina Fonsato, Joanna Fraczek, Rolf Gebhardt, Andrew Gibson, Matthias Glanemann, Christopher E. Goldring, Marı́a José Gómez-Lechón, Geny M. M. Groothuis, Lena Gustavsson, Christelle Guyot, David Hallifax, Seddik Hammad, Adam S. Hayward, Dieter Häussinger, Claus Hellerbrand, Philip Hewitt, Stefan Hoehme, Hermann−Georg Holzhütter, J. Brian Houston, Jens Hrach, Kiyomi Ito, Hartmut Jaeschke, Verena Keitel, Jens Kelm, B. Kevin Park, Claus Kordes, Gerd A. Kullak‐Ublick, Edward L. LeCluyse, Peng Lü, Jennifer L. Luebke-Wheeler, Anna Lutz, Daniel J. Maltman, Madlen Matz‐Soja, Patrick D. McMullen, Irmgard Merfort, Simon Messner, Christoph Meyer, Jessica Mwinyi, Dean J. Naisbitt, Andreas K. Nüssler, Peter Olinga, Francesco Pampaloni, Jingbo Pi, Linda Pluta, Stefan Przyborski, Anup Ramachandran, Vera Rogiers, Cliff Rowe, Celine Schelcher, Kathrin Schmich, Michael Schwarz, Bijay Singh, Ernst H. K. Stelzer, Bruno Stieger, Regina Stöber, Yuichi Sugiyama, Ciro Tetta, Wolfgang E. Thasler, Tamara Vanhaecke, Mathieu Vinken, Thomas S. Weiß, A Widera, Courtney G. Woods, Jinghai J. Xu, Kathy Yarborough, Jan G. Hengstler
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
Hideki Ueno, Tatsuya Ioka, Masafumi Ikeda, Shinichi Ohkawa, Hiroaki Yanagimoto, Narikazu Boku, Akira Fukutomi, Kazuya Sugimori, Hideo Baba, Kenji Yamao, T Shimamura, Masayuki Sho, Masayuki Kitano, Ann‐Lii Cheng, Kazuhiro Mizumoto, Jen‐Shi Chen, Junji Furuse, Akihiro Funakoshi, Takashi Hatori, Taketo Yamaguchi, Shinichi Egawa, Atsushi Satō, Yasuo Ohashi, Takuji Okusaka, Masao Tanaka
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
Kazuo Kimura, Takeshi Kimura, Masaharu Ishihara, Yoshihisa Nakagawa, Kōichi Nakao, Katsumi Miyauchi, Tomohiro Sakamoto, Kenichi Tsujita, Nobuhisa Hagiwara, Shunichi Miyazaki, Junya Ako, Hirokuni Arai, Hideki Ishii, Hideki Origuchi, Wataru Shimizu, Hirofumi Takemura, Yoshio Tahara, Yoshihiro Morino, Kenji Iino, Tomonori Itoh, Yoshitaka Iwanaga, Keiji Uchida, Hirohisa Endo, Ken Kongoji, Kenji Sakamoto, Hiroki Shiomi, Takao Shimohama, Atsushi Suzuki, Jun Takahashi, Ichiro Takeuchi, Akihito Tanaka, Toshihiro Tamura, Takahiro Nakashima, Teruo Noguchi, Daisuke Fukamachi, Tomohiro Mizuno, Junichi Yamaguchi, Kenji Yodogawa, Masami Kosuge, Shun Kohsaka, Hideaki Yoshino, Satoshi Yasuda, Hiroaki Shimokawa, Atsushi Hirayama, Takashi Akasaka, Kazuo Haze, Hisao Ogawa, Hiroyuki Tsutsui, Tsutomu Yamazaki, on behalf of the Japanese Circulation Society Joint Working Group
WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia
Kazushi Inoue, Haruo Sugiyama, Hiroyasu Ogawa, Masaru Nakagawa, T Yamagami, Haruo Miwa, K Kita, A Hiraoka, T Masaoka, K Nasu
How much of the research on Yokohama City University Medical Center is open access?
ScholarIQopen access share
42%OPEN ACCESS